Jaap den Engelsman is a global finance executive and founder with 30+ years of experience across biotechnology, renewable energy, nutrition, and advanced manufacturing, spanning Blue-Chip corporates, SMEs, and new ventures. Proven track record in scaling start-ups, leading complex business turnarounds, and guiding organisations through M&A, ownership transitions, and strategic exits.

Secured over US$70M in equity and government funding, implemented robust governance and risk frameworks, and co-piloted negotiation of high-value contracts with global pharmaceutical and industrial partners. Recognised for building financial infrastructure from the ground up, delivering double-digit performance improvements, and creating sustained shareholder value across multiple geographies. Passionate about building innovative and sustainable businesses delivering meaningful results.

Jaap has an MSc in Business Administration, and is a Graduate of the Australian Institute of Company Directors.